Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease

NCT02581124 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia of Chronic Kidney Disease

Interventions

DRUG: JTZ-951
DRUG: Lapatinib

Sponsor

Akros Pharma Inc.